社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Johnleong
IP属地：未知
+关注
帖子 · 22
帖子 · 22
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Johnleong
Johnleong
·
2021-10-14
$Plug Power(PLUG)$
finally moving. What is the target price
看
1,787
回复
1
点赞
2
编组 21备份 2
分享
举报
Johnleong
Johnleong
·
2021-10-07
Nice
非常抱歉，此主贴已删除
看
1,137
回复
评论
点赞
4
编组 21备份 2
分享
举报
Johnleong
Johnleong
·
2021-09-16
Great
非常抱歉，此主贴已删除
看
1,555
回复
2
点赞
3
编组 21备份 2
分享
举报
Johnleong
Johnleong
·
2021-07-22
Continue go higher?
非常抱歉，此主贴已删除
看
1,306
回复
评论
点赞
5
编组 21备份 2
分享
举报
Johnleong
Johnleong
·
2021-07-20
Wow
非常抱歉，此主贴已删除
看
2,036
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Johnleong
Johnleong
·
2021-07-19
Beware
Record Stock Rally Ignores Wall Street’s Phobia About Optimism
The latest victim of the rampaging bull market in stocks is the Wall Street maxim that glowing inves
Record Stock Rally Ignores Wall Street’s Phobia About Optimism
看
1,967
回复
2
点赞
1
编组 21备份 2
分享
举报
Johnleong
Johnleong
·
2021-07-18
Great
U.S. administers 337.24 million doses of COVID-19 vaccines - CDC
July 17 (Reuters) - The United States has administered 337,239,448 doses of COVID-19 vaccines in the
U.S. administers 337.24 million doses of COVID-19 vaccines - CDC
看
1,073
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Johnleong
Johnleong
·
2021-07-17
Great
FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit
July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nit
FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit
看
2,095
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Johnleong
Johnleong
·
2021-07-17
Great
FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit
July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nit
FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit
看
1,389
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Johnleong
Johnleong
·
2021-07-16
Wow
非常抱歉，此主贴已删除
看
873
回复
评论
点赞
3
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3581975110248198","uuid":"3581975110248198","gmtCreate":1618881283365,"gmtModify":1704447472210,"name":"Johnleong","pinyin":"johnleong","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":391,"tweetSize":22,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.12","exceedPercentage":"60.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.21","exceedPercentage":"60.03%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":822772774,"gmtCreate":1634174698733,"gmtModify":1634174698733,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$</a>finally moving. What is the target price","listText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$</a>finally moving. What is the target price","text":"$Plug Power(PLUG)$finally moving. What is the target price","images":[{"img":"https://static.tigerbbs.com/86d8544baa21b7e427052e9e87a65a14","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/822772774","isVote":1,"tweetType":1,"viewCount":1787,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":823042249,"gmtCreate":1633567692080,"gmtModify":1633567790725,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823042249","repostId":"2173948202","repostType":4,"isVote":1,"tweetType":1,"viewCount":1137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":885955575,"gmtCreate":1631752909797,"gmtModify":1631891504611,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/885955575","repostId":"2167592712","repostType":4,"isVote":1,"tweetType":1,"viewCount":1555,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176730905,"gmtCreate":1626915062207,"gmtModify":1631891504623,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"themes":[],"htmlText":"Continue go higher?","listText":"Continue go higher?","text":"Continue go higher?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176730905","repostId":"2153477496","repostType":4,"isVote":1,"tweetType":1,"viewCount":1306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171855717,"gmtCreate":1626738825439,"gmtModify":1631891504638,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171855717","repostId":"2152265779","repostType":2,"isVote":1,"tweetType":1,"viewCount":2036,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173671566,"gmtCreate":1626659863555,"gmtModify":1631891504650,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"themes":[],"htmlText":"Beware","listText":"Beware","text":"Beware","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/173671566","repostId":"1123426523","repostType":2,"repost":{"id":"1123426523","kind":"news","pubTimestamp":1626656489,"share":"https://www.laohu8.com/m/news/1123426523?lang=&edition=full","pubTime":"2021-07-19 09:01","market":"us","language":"en","title":"Record Stock Rally Ignores Wall Street’s Phobia About Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=1123426523","media":"WSJ","summary":"The latest victim of the rampaging bull market in stocks is the Wall Street maxim that glowing inves","content":"<p>The latest victim of the rampaging bull market in stocks is the Wall Street maxim that glowing investor sentiment is a sell signal.</p>\n<p>Throughout 2021, a range of surveys, fund-flow figures and options activity have shown investors big and small to be exceptionally bullish. Yet major U.S. indexes continue to rally to records, putting the Dow Jones Industrial Average up a healthy 13% for 2021.</p>\n<p>Analysts have long relied on sentiment and related data on risk-taking as contrarian indicators. By the time friends, colleagues and strangers are plowing money into stocks and telling you about it, it’s time to run for cover, to this way of thinking. Likewise, when everyone is selling, you should be buying with both hands.</p>\n<p>But for much of this year, it has paid enormous dividends to stay with the herd. It’s the latest departure from the tried and true in a year that already has broughtsoaring meme stocks,record lumber pricesand a bond-market rally in the face of rising inflation. In short, now is when analysts and portfolio managers are starting to wonder whether it really is different this time.</p>\n<p>“We’ve been throwing up our hands for a while,” said Jason Goepfert, president of Sundial Capital Research. “For whatever the reason, the market is just rolling over all these historical indicators that before had a very consistent track record.”</p>\n<p>In the coming week, traders will parse data on housing starts and building permits, as well as earnings from companies including Johnson & Johnson andUnited Airlines HoldingsInc.,for further clues about pricing pressures.</p>\n<p>They will also be watching to see if sentiment oscillates. Recently, signs of waning sentiment have begun peeking through some indicators, though bullishness largely remains above or near long-term averages.</p>\n<p>Americans’ stock allocations reached nearly 60% at the end of March, a figure just below the all-time high of 61.7% reached during the dot-com bubble, according to data from Ned Davis Research stretching back to 1951.</p>\n<p>A July survey by retail brokerage E*Trade found that bullishness among the platform’s individual investors recently hit more than a three-year high, rising to 65%. Additionally, the often-watched equity put-call ratio—which measures the volume of bearish options bets placed on stocks versus bullish ones—earlier this year notched sustained levels of optimism not seen since 2000.</p>\n<p>The source of the optimism that has fueled 39 records this year on the S&P 500 isn’t hard to divine. Most notably, there’s an unusual and powerful blend of stimulus and easy monetary policy that has left investors flush with cash and with few sources of steady investment returns. The entrance ofa new cohort of retail tradershas provided an extra boost to prices, too.</p>\n<p>Analysts say the combination of those factors has pushed markets higher, providing traders with enough momentum and opportunity to ignore signs of stretched sentiment—as well as other risks, including an unclear inflation outlook andrising coronavirus cases.</p>\n<p>Recently, market breadth, or a measure of how many stocks are participating in a rally, has deteriorated—even as major indexes have continued to hit all-time highs.</p>\n<p>As of Thursday, only about 49% of stocks in the S&P 500 traded above their 50-day moving averages, according to FactSet, a level that is below average and one that is a sharp reversal from just a few months ago, whenthat metric reached more than 90%. According to Liz Ann Sonders, chief investment strategist at Charles Schwab, that’s a troubling sign when sentiment remains so high.</p>\n<p>“Any longtime sentiment watcher knows that breadth is a positive offset to extreme sentiment conditions,” Ms. Sonders said. “But when breadth starts to deteriorate and the market is still trading at or near all-time highs, and there’s been no dent to sentiment conditions, that’s when trouble really brews.”</p>\n<p>But sentiment can remain elevated for long periods, as it did in the late 1990s, she said. And while major indexes have risen, pockets of excess have lost steam.</p>\n<p>“In places where speculation has been rampant, you have seen massive drawdowns—in cryptocurrencies, [special-purpose acquisition companies], nonprofitable tech companies and meme stocks,” Ms. Sonders said.</p>\n<p>According a recent Charles Schwab note based on data from Ned Davis Research, when stockholdings among U.S. households have previously climbed to among the highest levels, the S&P 500 has tended to produce modest returns on average in following years. For example, when households’ stock allocations have risen to 54.6% or higher—as they did during the dot-com bubble and the years leading up to the 2007-09 recession—the average annualized return for the S&P 500 over the next 10 years has been 4.1%.</p>\n<p>In contrast, when stock allocations have hovered around 29% or lower, the average annualized return over the next 10 years for the benchmark index has been 16.3%.</p>\n<p>Even so, unique conditions within the market this year might allow stocks to keep grinding higher.</p>\n<p>“Markets are just doing their own thing,” Mr. Goepfert said. “Something has changed. Whether it’s unprecedented stimulus or maybe there is this generational change with young investors. This new surge into the market keeps driving stocks higher.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Record Stock Rally Ignores Wall Street’s Phobia About Optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRecord Stock Rally Ignores Wall Street’s Phobia About Optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-19 09:01 GMT+8 <a href=https://www.wsj.com/articles/record-stock-rally-ignores-wall-streets-phobia-about-optimism-11626600781?mod=hp_lead_pos5><strong>WSJ</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The latest victim of the rampaging bull market in stocks is the Wall Street maxim that glowing investor sentiment is a sell signal.\nThroughout 2021, a range of surveys, fund-flow figures and options ...</p>\n\n<a href=\"https://www.wsj.com/articles/record-stock-rally-ignores-wall-streets-phobia-about-optimism-11626600781?mod=hp_lead_pos5\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UAL":"联合大陆航空","JNJ":"强生"},"source_url":"https://www.wsj.com/articles/record-stock-rally-ignores-wall-streets-phobia-about-optimism-11626600781?mod=hp_lead_pos5","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123426523","content_text":"The latest victim of the rampaging bull market in stocks is the Wall Street maxim that glowing investor sentiment is a sell signal.\nThroughout 2021, a range of surveys, fund-flow figures and options activity have shown investors big and small to be exceptionally bullish. Yet major U.S. indexes continue to rally to records, putting the Dow Jones Industrial Average up a healthy 13% for 2021.\nAnalysts have long relied on sentiment and related data on risk-taking as contrarian indicators. By the time friends, colleagues and strangers are plowing money into stocks and telling you about it, it’s time to run for cover, to this way of thinking. Likewise, when everyone is selling, you should be buying with both hands.\nBut for much of this year, it has paid enormous dividends to stay with the herd. It’s the latest departure from the tried and true in a year that already has broughtsoaring meme stocks,record lumber pricesand a bond-market rally in the face of rising inflation. In short, now is when analysts and portfolio managers are starting to wonder whether it really is different this time.\n“We’ve been throwing up our hands for a while,” said Jason Goepfert, president of Sundial Capital Research. “For whatever the reason, the market is just rolling over all these historical indicators that before had a very consistent track record.”\nIn the coming week, traders will parse data on housing starts and building permits, as well as earnings from companies including Johnson & Johnson andUnited Airlines HoldingsInc.,for further clues about pricing pressures.\nThey will also be watching to see if sentiment oscillates. Recently, signs of waning sentiment have begun peeking through some indicators, though bullishness largely remains above or near long-term averages.\nAmericans’ stock allocations reached nearly 60% at the end of March, a figure just below the all-time high of 61.7% reached during the dot-com bubble, according to data from Ned Davis Research stretching back to 1951.\nA July survey by retail brokerage E*Trade found that bullishness among the platform’s individual investors recently hit more than a three-year high, rising to 65%. Additionally, the often-watched equity put-call ratio—which measures the volume of bearish options bets placed on stocks versus bullish ones—earlier this year notched sustained levels of optimism not seen since 2000.\nThe source of the optimism that has fueled 39 records this year on the S&P 500 isn’t hard to divine. Most notably, there’s an unusual and powerful blend of stimulus and easy monetary policy that has left investors flush with cash and with few sources of steady investment returns. The entrance ofa new cohort of retail tradershas provided an extra boost to prices, too.\nAnalysts say the combination of those factors has pushed markets higher, providing traders with enough momentum and opportunity to ignore signs of stretched sentiment—as well as other risks, including an unclear inflation outlook andrising coronavirus cases.\nRecently, market breadth, or a measure of how many stocks are participating in a rally, has deteriorated—even as major indexes have continued to hit all-time highs.\nAs of Thursday, only about 49% of stocks in the S&P 500 traded above their 50-day moving averages, according to FactSet, a level that is below average and one that is a sharp reversal from just a few months ago, whenthat metric reached more than 90%. According to Liz Ann Sonders, chief investment strategist at Charles Schwab, that’s a troubling sign when sentiment remains so high.\n“Any longtime sentiment watcher knows that breadth is a positive offset to extreme sentiment conditions,” Ms. Sonders said. “But when breadth starts to deteriorate and the market is still trading at or near all-time highs, and there’s been no dent to sentiment conditions, that’s when trouble really brews.”\nBut sentiment can remain elevated for long periods, as it did in the late 1990s, she said. And while major indexes have risen, pockets of excess have lost steam.\n“In places where speculation has been rampant, you have seen massive drawdowns—in cryptocurrencies, [special-purpose acquisition companies], nonprofitable tech companies and meme stocks,” Ms. Sonders said.\nAccording a recent Charles Schwab note based on data from Ned Davis Research, when stockholdings among U.S. households have previously climbed to among the highest levels, the S&P 500 has tended to produce modest returns on average in following years. For example, when households’ stock allocations have risen to 54.6% or higher—as they did during the dot-com bubble and the years leading up to the 2007-09 recession—the average annualized return for the S&P 500 over the next 10 years has been 4.1%.\nIn contrast, when stock allocations have hovered around 29% or lower, the average annualized return over the next 10 years for the benchmark index has been 16.3%.\nEven so, unique conditions within the market this year might allow stocks to keep grinding higher.\n“Markets are just doing their own thing,” Mr. Goepfert said. “Something has changed. Whether it’s unprecedented stimulus or maybe there is this generational change with young investors. This new surge into the market keeps driving stocks higher.”","news_type":1,"symbols_score_info":{"JNJ":0.9,"UAL":0.9}},"isVote":1,"tweetType":1,"viewCount":1967,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179435356,"gmtCreate":1626570547875,"gmtModify":1631891504660,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/179435356","repostId":"2152812616","repostType":2,"repost":{"id":"2152812616","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626559168,"share":"https://www.laohu8.com/m/news/2152812616?lang=&edition=full","pubTime":"2021-07-18 05:59","market":"sh","language":"en","title":"U.S. administers 337.24 million doses of COVID-19 vaccines - CDC","url":"https://stock-news.laohu8.com/highlight/detail?id=2152812616","media":"Reuters","summary":"July 17 (Reuters) - The United States has administered 337,239,448 doses of COVID-19 vaccines in the","content":"<html><body><p>July 17 (Reuters) - The United States has administered 337,239,448 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 390,100,705 doses, the U.S. Centers for Disease Control and Prevention said on Saturday.</p><p> Those figures are up from the 336,604,158 doses the CDC said had gone into arms by Friday, out of 389,359,835 doses delivered.</p><p> The agency said 185,765,452 people had received at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> dose while 160,994,035 people were fully vaccinated as of Saturday.</p><p> The CDC tally includes two-dose vaccines from Moderna</p><p> and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine as of 6:00 a.m. ET on Saturday.</p><p> (Editing by Richard Chang)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. administers 337.24 million doses of COVID-19 vaccines - CDC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. administers 337.24 million doses of COVID-19 vaccines - CDC\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-18 05:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>July 17 (Reuters) - The United States has administered 337,239,448 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 390,100,705 doses, the U.S. Centers for Disease Control and Prevention said on Saturday.</p><p> Those figures are up from the 336,604,158 doses the CDC said had gone into arms by Friday, out of 389,359,835 doses delivered.</p><p> The agency said 185,765,452 people had received at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> dose while 160,994,035 people were fully vaccinated as of Saturday.</p><p> The CDC tally includes two-dose vaccines from Moderna</p><p> and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine as of 6:00 a.m. ET on Saturday.</p><p> (Editing by Richard Chang)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","JNJ":"强生","PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152812616","content_text":"July 17 (Reuters) - The United States has administered 337,239,448 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 390,100,705 doses, the U.S. Centers for Disease Control and Prevention said on Saturday. Those figures are up from the 336,604,158 doses the CDC said had gone into arms by Friday, out of 389,359,835 doses delivered. The agency said 185,765,452 people had received at least one dose while 160,994,035 people were fully vaccinated as of Saturday. The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine as of 6:00 a.m. ET on Saturday. (Editing by Richard Chang)","news_type":1,"symbols_score_info":{"JNJ":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1073,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179385588,"gmtCreate":1626486785244,"gmtModify":1631891504672,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/179385588","repostId":"2152068390","repostType":2,"repost":{"id":"2152068390","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1626467099,"share":"https://www.laohu8.com/m/news/2152068390?lang=&edition=full","pubTime":"2021-07-17 04:24","market":"us","language":"en","title":"FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit","url":"https://stock-news.laohu8.com/highlight/detail?id=2152068390","media":"T-Reuters","summary":"July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nit","content":"<html><body><p>July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nitrosamine Below The Interim Acceptable Intake Limit.Fda - Will Not Object To Distribution Of Varenicline Tablets With N-Nitroso-Varenicline Below Interim Acceptable Intake Limit Of 185 Ng Per Day.Fda - Continues To Evaluate Data And May Update The Interim Acceptable Limit Of Nitrosamine In Varenicline Tablets In The Future.Further Company Coverage: Pfe.N. ((Reuters.Briefs@Thomsonreuters.Com;)).</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-07-17 04:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nitrosamine Below The Interim Acceptable Intake Limit.Fda - Will Not Object To Distribution Of Varenicline Tablets With N-Nitroso-Varenicline Below Interim Acceptable Intake Limit Of 185 Ng Per Day.Fda - Continues To Evaluate Data And May Update The Interim Acceptable Limit Of Nitrosamine In Varenicline Tablets In The Future.Further Company Coverage: Pfe.N. ((Reuters.Briefs@Thomsonreuters.Com;)).</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152068390","content_text":"July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nitrosamine Below The Interim Acceptable Intake Limit.Fda - Will Not Object To Distribution Of Varenicline Tablets With N-Nitroso-Varenicline Below Interim Acceptable Intake Limit Of 185 Ng Per Day.Fda - Continues To Evaluate Data And May Update The Interim Acceptable Limit Of Nitrosamine In Varenicline Tablets In The Future.Further Company Coverage: Pfe.N. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2095,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179385931,"gmtCreate":1626486763323,"gmtModify":1631891504687,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/179385931","repostId":"2152068390","repostType":2,"repost":{"id":"2152068390","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1626467099,"share":"https://www.laohu8.com/m/news/2152068390?lang=&edition=full","pubTime":"2021-07-17 04:24","market":"us","language":"en","title":"FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit","url":"https://stock-news.laohu8.com/highlight/detail?id=2152068390","media":"T-Reuters","summary":"July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nit","content":"<html><body><p>July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nitrosamine Below The Interim Acceptable Intake Limit.Fda - Will Not Object To Distribution Of Varenicline Tablets With N-Nitroso-Varenicline Below Interim Acceptable Intake Limit Of 185 Ng Per Day.Fda - Continues To Evaluate Data And May Update The Interim Acceptable Limit Of Nitrosamine In Varenicline Tablets In The Future.Further Company Coverage: Pfe.N. ((Reuters.Briefs@Thomsonreuters.Com;)).</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-07-17 04:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nitrosamine Below The Interim Acceptable Intake Limit.Fda - Will Not Object To Distribution Of Varenicline Tablets With N-Nitroso-Varenicline Below Interim Acceptable Intake Limit Of 185 Ng Per Day.Fda - Continues To Evaluate Data And May Update The Interim Acceptable Limit Of Nitrosamine In Varenicline Tablets In The Future.Further Company Coverage: Pfe.N. ((Reuters.Briefs@Thomsonreuters.Com;)).</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152068390","content_text":"July 16 (Reuters) - U.S. Fda: :Fda Will Not Object To Distribution Of Chantix (Varenicline) With Nitrosamine Below The Interim Acceptable Intake Limit.Fda - Will Not Object To Distribution Of Varenicline Tablets With N-Nitroso-Varenicline Below Interim Acceptable Intake Limit Of 185 Ng Per Day.Fda - Continues To Evaluate Data And May Update The Interim Acceptable Limit Of Nitrosamine In Varenicline Tablets In The Future.Further Company Coverage: Pfe.N. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170054230,"gmtCreate":1626396961420,"gmtModify":1631891504707,"author":{"id":"3581975110248198","authorId":"3581975110248198","name":"Johnleong","avatar":"https://static.tigerbbs.com/bf6ab9717d202c58a631934c5f8abd6b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581975110248198","authorIdStr":"3581975110248198"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170054230","repostId":"1107139193","repostType":2,"isVote":1,"tweetType":1,"viewCount":873,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}